Craig Langman

PowerPoint Slides for: A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme

Langman, C. (Creator), Grujic, D. (Creator), Pease, R. M. (Creator), Easter, L. (Creator), Nezzer, J. (Creator), Margolin, A. (Creator) & Brettman, L. (Creator), Karger Publishers, 2016

DOI: 10.6084/m9.figshare.3635727.v3, https://karger.figshare.com/articles/dataset/PowerPoint_Slides_for_A_Double-Blind_Placebo_Controlled_Randomized_Phase_1_Cross-Over_Study_with_ALLN-177_an_Orally_Administered_Oxalate_Degrading_Enzyme/3635727/3

Dataset

PowerPoint Slides for: A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme

Langman, C. (Creator), Grujic, D. (Creator), Pease, R. M. (Creator), Easter, L. (Creator), Nezzer, J. (Creator), Margolin, A. (Creator) & Brettman, L. (Creator), Karger Publishers, 2016

DOI: 10.6084/m9.figshare.3635727.v2, https://karger.figshare.com/articles/dataset/PowerPoint_Slides_for_A_Double-Blind_Placebo_Controlled_Randomized_Phase_1_Cross-Over_Study_with_ALLN-177_an_Orally_Administered_Oxalate_Degrading_Enzyme/3635727/2

Dataset

Supplementary Material for: Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan

Podos, S. D. (Contributor), Trachtman, H. (Contributor), Appel, G. B. (Contributor), Bomback, A. S. (Contributor), Dixon, B. P. (Contributor), Wetzels, J. F. M. (Contributor), Cook, H. T. (Contributor), Parikh, S. V. (Contributor), Pickering, M. C. (Contributor), Tumlin, J. (Contributor), Langman, C. (Contributor), Lightstone, L. (Contributor), Sperati, C. J. (Contributor), Daina, E. (Contributor), Bouman, K. P. (Contributor), Rice, K. (Contributor), Thanassi, J. A. (Contributor), Huang, M. (Contributor), Nester, C. (Contributor) & Remuzzi, G. (Contributor), Karger Publishers, 2022

DOI: 10.6084/m9.figshare.21582873.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Baseline_Clinical_Characteristics_and_Complement_Biomarkers_of_Patients_with_C3_Glomerulopathy_Enrolled_in_Two_Phase_2_Studies_Investigating_the_Factor_D_Inhibitor_Danicopan/21582873/1

Dataset

Supplementary Material for: A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme

Langman, C. (Creator), Grujic, D. (Creator), Pease, R. M. (Creator), Easter, L. (Creator), Nezzer, J. (Creator), Margolin, A. (Creator) & Brettman, L. (Creator), figshare, 2016

DOI: 10.6084/m9.figshare.3593286, https://figshare.com/articles/Supplementary_Material_for_A_Double-Blind_Placebo_Controlled_Randomized_Phase_1_Cross-Over_Study_with_ALLN-177_an_Orally_Administered_Oxalate_Degrading_Enzyme/3593286

Dataset

PowerPoint Slides for: A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme

Langman, C. (Creator), Grujic, D. (Creator), Pease, R. M. (Creator), Easter, L. (Creator), Nezzer, J. (Creator), Margolin, A. (Creator) & Brettman, L. (Creator), figshare, 2016

DOI: 10.6084/m9.figshare.3635727, https://figshare.com/articles/PowerPoint_Slides_for_A_Double-Blind_Placebo_Controlled_Randomized_Phase_1_Cross-Over_Study_with_ALLN-177_an_Orally_Administered_Oxalate_Degrading_Enzyme/3635727

Dataset

Supplementary Material for: A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme

Langman, C. (Creator), Grujic, D. (Creator), Pease, R. M. (Creator), Easter, L. (Creator), Nezzer, J. (Creator), Margolin, A. (Creator) & Brettman, L. (Creator), Karger Publishers, 2016

DOI: 10.6084/m9.figshare.3593286.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_A_Double-Blind_Placebo_Controlled_Randomized_Phase_1_Cross-Over_Study_with_ALLN-177_an_Orally_Administered_Oxalate_Degrading_Enzyme/3593286/1

Dataset

PowerPoint Slides for: A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme

Langman, C. (Creator), Grujic, D. (Creator), Pease, R. M. (Creator), Easter, L. (Creator), Nezzer, J. (Creator), Margolin, A. (Creator) & Brettman, L. (Creator), Karger Publishers, 2016

DOI: 10.6084/m9.figshare.3635727.v1, https://karger.figshare.com/articles/dataset/PowerPoint_Slides_for_A_Double-Blind_Placebo_Controlled_Randomized_Phase_1_Cross-Over_Study_with_ALLN-177_an_Orally_Administered_Oxalate_Degrading_Enzyme/3635727/1

Dataset

Supplementary Material for: Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies

Nester, C. (Contributor), Appel, G. B. (Contributor), Bomback, A. S. (Contributor), Bouman, K. P. (Contributor), Cook, H. T. (Contributor), Daina, E. (Contributor), Dixon, B. P. (Contributor), Rice, K. (Contributor), Najafian, N. (Contributor), Hui, J. (Contributor), Langman, C. (Contributor), Lightstone, L. (Contributor), Parikh, S. V. (Contributor), Pickering, M. C. (Contributor), Sperati, C. J. (Contributor), Trachtman, H. (Contributor), Tumlin, J. (Contributor), Wetzels, J. F. M. (Contributor) & Remuzzi, G. (Contributor), Karger Publishers, 2022

DOI: 10.6084/m9.figshare.21617358, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Clinical_Outcomes_of_Patients_with_C3G_or_IC-MPGN_Treated_with_the_Factor_D_Inhibitor_Danicopan_Final_Results_from_Two_Phase_2_Studies/21617358

Dataset

Supplementary Material for: Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies

Nester, C. (Contributor), Appel, G. B. (Contributor), Bomback, A. S. (Contributor), Bouman, K. P. (Contributor), Cook, H. T. (Contributor), Daina, E. (Contributor), Dixon, B. P. (Contributor), Rice, K. (Contributor), Najafian, N. (Contributor), Hui, J. (Contributor), Langman, C. (Contributor), Lightstone, L. (Contributor), Parikh, S. V. (Contributor), Pickering, M. C. (Contributor), Sperati, C. J. (Contributor), Trachtman, H. (Contributor), Tumlin, J. (Contributor), Wetzels, J. F. M. (Contributor) & Remuzzi, G. (Contributor), Karger Publishers, 2022

DOI: 10.6084/m9.figshare.21617358.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Clinical_Outcomes_of_Patients_with_C3G_or_IC-MPGN_Treated_with_the_Factor_D_Inhibitor_Danicopan_Final_Results_from_Two_Phase_2_Studies/21617358/1

Dataset

Craig Langman

Datasets

Search results